|
| [ На главную ] -- [ Список участников ] -- [ Правила форума ] -- [ Зарегистрироваться ] |
| On-line: |
| Клуб болельщиков "Торпедо" Владимир / / atJsHHNejo |
| Страницы: 1 |
|
| Автор | Сообщение |
|
Ashley Гость |
Добавлено: 07-06-2022 02:04 |
|
I'll put him on metoprolol and atenolol are under what generation AstraZeneca's problems are not unique, but its patent expiries are bigger and longer-lasting than at rivals such as British peer GlaxoSmithKline. Its pure focus on prescription drugs also means it lacks the buffer of consumer-focused sales seen at the likes of GSK and Switzerland's Novartis. |
| Страницы: 1 |
|
| Клуб болельщиков "Торпедо" Владимир / / atJsHHNejo |